Primary urothelial carcinoma of the upper tract: Important clinicopathological factors predicting bladder recurrence after surgical resection

Pathology International

Volumn 59, Issue 9, 2009, Pages 642-649

  Huang, Wen Wei ^a,b   Huang, Hsuan Ying ^c   Liao, Alex C ^d   Shiue, Yow Ling ^e   Tai, Hsiu Lun ^d   Lin, Chun Mao ^f   Wang, Yu Hui ^d   Lin, Ching Nan ^d   Shen, Kun Hung ^d   Li, Chien Feng ^d,e  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Upper urinary tract; Urinary bladder recurrence; Urothelial carcinoma

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SEX DIFFERENCE; TREATMENT OUTCOME; URETERECTOMY; URINARY TRACT CARCINOMA; UROLOGIC SURGERY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETEROSCOPY; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 68949107975     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02420.x     Document Type: Article

References (36)

1. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003 47 : 155 69.
2. Terakawa T, Miyake H, Muramaki M et al. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 2008 71 : 123 7.
3. Matsui Y, Utsunomiya N, Ichioka K et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005 65 : 279 83.
4. Zigeuner RE, Hutterer G, Chromecki T et al. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 2006 98 : 1181 6.
5. Jarrett TW, Chan DY, Cadeddu JA et al. Laparoscopic nephroureterectomy for the treatment of transitional cell carcinoma of the upper urinary tract. Urology 2001 57 : 448 53.
6. Hall MC, Womack S, Sagalowsky AI et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 1998 52 : 594 601.
7. Hisataki T, Miyao N, Masumori N et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology 2000 55 : 663 7.
8. Mukamel E, Simon D, Edelman A et al. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma. J Surg Oncol 1994 57 : 187 90.
9. Tsai YS, Tzai TS, Chow NH et al. Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract. Urology 2005 66 : 1197 202.
10. Koga F, Nagamatsu H, Ishimaru H et al. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol Int 2001 67 : 135 41.
11. Li CC, Chang TH, Wu WJ et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008 54 : 1127 34.
12. Liaw KF, Horng SF, Lin LJ et al. A cohort study on lower urinary tract cancers in the endemic area of blackfoot disease. Chin J Public Health (Taipei) 1995 14 : 23 31.
13. Lopez-Beltran A, Sauter G, Gasser T et al. Tumour of the urinary system. Infiltrating urothelial carcinoma. In : Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004 93 109.
14. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors, 6th edn. New York, Wiley-Liss, 2002.
15. Jimenez RE, Gheiler E, Oskanian P et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000 24 : 980 87.
16. Remzi M, Haitel A, Margulis V et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: A multi-institutional analysis of 1363 patients. BJU Int 2009 103 : 307 11.
17. Kang CH, Yu TJ, Hsieh HH et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003 98 : 1620 26.
18. Murta CB, Antunes AA, Dall'oglio MF et al. Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma. Clinics 2008 63 : 223 8.
19. Eng MK, Shalhav AL. Laparoscopic nephroureterectomy: Long-term outcomes. Curr Opin Urol 2008 18 : 157 62.
20. Morioka M, Jo Y, Furukawa Y et al. Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 2001 8 : 366 73.
21. Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 2006 176 : 48 52.
22. Hafner C, Knuechel R, Zanardo L et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 2001 20 : 4910 15.
23. Herawi M, Leppert JT, Thomas GV et al. Implants of noninvasive papillary urothelial carcinoma in peritoneum and ileocolonic neobladder: Support for 'seed and soil' hypothesis of bladder recurrence. Urology 2006 67 : 746 50.
24. Kakizoe T. Development and progression of urothelial carcinoma. Cancer Sci 2006 97 : 821 8.
25. Jones TD, Wang M, Eble JN et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005 11 : 6512 19.
26. Pycha A, Mian C, Hofbauer J et al. Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium. Urology 1999 53 : 92 7.
27. Sidransky D, Frost P, Von Eschenbach A et al. Clonal origin bladder cancer. N Engl J Med 1992 326 : 737 40.
28. Hainaut P, Hernandez T, Robinson A et al. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 1998 26 : 205 13.
29. Hollstein M, Hergenhahn M, Yang Q et al. New approaches to understanding p53gene tumor mutation spectra. Mutat Res 1999 431 : 199 209.
30. Mao L, Lee DJ, Tockman MS et al. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 1994 91 : 9871 5.
31. Ito N. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Cancer Res 1976 36 : 2528 31.
32. Miyamoto H, Yang Z, Chen YT et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007 997 : 558 68.
33. Saito K, Kawakami S, Fujii Y et al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007 178 : 2291 6.
34. Kikuchi E, Horiguchi Y, Nakashima J et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 2005 174 : 2120 23.
35. Wu CF, Pang ST, Chen CS et al. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma. J Urol 2007 178 : 446 50.
36. Chen CJ, Chen CW, Wu MM et al. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992 66 : 888 92.